Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
HealthQuest Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
HealthQuest Capital

HealthQuest Capital

Operating

HealthQuest Capital, a private equity firm, invests in transformative healthcare companies to enhance patient outcomes and healthcare efficiency.

Location
Redwood City, CA, US
Founded
2013
Firm
Compare
Portfolio
Employees
Website

Investments

Connie Health
Connie Health
Series B

Total Raised

$56M

Rounds

3

Series B$40MJune 2026
Inbound Health
Inbound Health

Total Raised

$50M

Rounds

2

Series B$30MSeptember 2023
Clearsense
Clearsense

Total Raised

$125.5M

Rounds

4

Series D$50MJanuary 2023
Nomad Health
Nomad Health

Total Raised

$218M

Rounds

9

Series Unknown$105MJune 2022
Magnolia Medical Technologies
Magnolia Medical Technologies

Total Raised

$117.3M

Rounds

9

Series Unknown$46MFebruary 2022
Series C$20MJanuary 2019
Series B$13.8MJuly 2016
RareCyte
RareCyte
Public

Total Raised

$76M

Rounds

5

Series G$24MSeptember 2021
Series F$22MDecember 2019
Thirty Madison
Thirty Madison

Total Raised

$228.3M

Rounds

5

Series C$140MJune 2021
Everly Well
Everly Well

Total Raised

$325M

Rounds

7

Secondary Market$75MJanuary 2021
TigerConnect
TigerConnect

Total Raised

$448.9M

Rounds

8

Series D$45MOctober 2020
Pulmonx
Pulmonx
Public

Total Raised

$276.9M

Rounds

12

Series H$66MMay 2020
Ajax Health
Ajax Health

Total Raised

$315M

Rounds

4

Series C$15MJune 2019
Series C$85MApril 2019
Series B$120MJuly 2018
Trice Medical
Trice Medical

Total Raised

$106.2M

Rounds

9

Series C$18.3MJanuary 2019
Series C$19.3MJune 2017
CleanSlate Centers
CleanSlate Centers

Total Raised

$25M

Rounds

1

Series Unknown$25MMay 2018
Springbuk
Springbuk

Total Raised

$42.4M

Rounds

4

Series B$20MJanuary 2018
Vestagen Technical Textiles
Vestagen Technical Textiles
Acquired

Total Raised

$36.1M

Rounds

6

Series Unknown$9.5MOctober 2017
Series Unknown$7MFebruary 2016
Alcresta
Alcresta

Total Raised

$139.4M

Rounds

5

Series C$60MSeptember 2017
First Aid Shot Therapy
First Aid Shot Therapy

Total Raised

$31M

Rounds

3

Series C$24MNovember 2015
inMediata
inMediata

Total Raised

$12.8M

Rounds

3

Series Unknown$4MOctober 2015